← back to database
We focus on high-growth, disruptive businesses with innovative products and services that have a proven business model in sectors where we believe the upside is enormous.
Stage focus
Lead / follow
Check size
Ownership target
Generalist / Specialist
Generalist
Does not invest in
Biotech, pharma
Investing team
Andy AppelbaumManaging Partner
Danny CohenPrincipal
Spencer KrugPartner